25.36
Weefseltransplantatie is een belangrijke medische procedure waarbij cellen, weefsels of organen van een donor naar een ontvanger worden overgebracht,…
Tissue transplantation is a complex yet vital medical procedure that involves transferring cells, tissues, or organs from a donor to a recipient to restore lost functions.
This procedure relies heavily on the presence of MHC or HLA molecules, which are essential in distinguishing 'self' and 'non-self' cells.
These MHC molecules are unique to every individual due to the presence of multiple MHC proteins on cells, MHC gene polymorphism, and multiple alleles for each MHC locus.
So, finding a suitable donor whose MHC molecules match those of the recipient is a primary challenge. A successful transplant requires a match between at least 3–4 MHC molecules.
A mismatch between the MHC molecules of a donor organ and the recipient can trigger a cytotoxic T-cell response, often leading to transplant rejection.
Despite many challenges, the therapeutic potential of tissue transplantation is substantial. For instance, end-stage liver failure, heart failure, or diseases like Severe Combined Immunodeficiency are successfully treated through organ transplantation.
View the full transcript and gain access to JoVE Core videos
Q1: Why are MHC molecules important in tissue transplantation?
MHC molecules are essential for distinguishing 'self' and 'non-self' cells. The immune system recognizes foreign MHC molecules on transplanted tissue and can trigger a cytotoxic T cells mediated immune response, leading to transplant rejection. Each individual has a unique set of MHC molecules due to gene polymorphism and multiple alleles, making donor-recipient matching critical for transplant success.
Q2: What does MHC polymorphism mean in the context of transplantation?
MHC polymorphism refers to the presence of multiple alleles for each MHC locus, creating vast genetic variation among individuals. Combined with polygeny—the presence of multiple MHC proteins on cells—this polymorphism makes each person's MHC profile unique. This genetic diversity is why finding a suitable donor match is extremely challenging and often requires searching worldwide databases.
Q3: How many MHC molecules must match for a successful transplant?
A successful transplant typically requires a match between at least 3–4 MHC molecules between donor and recipient. More matches are associated with increased success rates and reduced risk of rejection. However, achieving even this minimum level of matching is difficult due to the extensive polymorphisms in MHC molecules across the population.
Q4: What conditions can be treated with tissue transplantation?
Tissue transplantation treats end-stage organ failure including heart, liver, and kidney failure. Bone marrow transplants successfully address Severe Combined Immunodeficiency and leukemia. However, bone marrow transplants can cause graft-versus-host disease, where transplanted cells attack recipient tissues, leading to multiple organ damage and requiring careful management.
Q5: What is graft-versus-host disease in bone marrow transplants?
Graft-versus-host disease occurs when transplanted bone marrow cells attack the recipient's own tissues, causing damage to multiple organs. This complication represents a significant challenge in bone marrow transplantation. While efforts continue to moderate its effects, it remains an important consideration when evaluating the risks and benefits of bone marrow transplants for patients.
Q6: Why is finding a donor match so difficult in tissue transplantation?
Finding a donor match is challenging because MHC molecules exhibit both polygeny and polymorphism, creating unique profiles for each individual. The extensive genetic variation in MHC loci means compatible donors are rare. Searches often extend to worldwide databases to locate unrelated donors whose MHC molecules sufficiently match the recipient's profile.
Q7: How does the immune system respond to mismatched MHC molecules?
When donor and recipient MHC molecules mismatch, the immune system recognizes the transplanted tissue as foreign. This triggers an adaptive immune response, particularly a cytotoxic T-cell response that attacks and destroys the transplanted tissue. This immune rejection is the primary barrier to successful transplantation and is why MHC matching is so critical.